# begin document GENTLE_medical_transplant
0	Description	(abstract-1)
1	:	(2)
2	Posttransplant	(abstract-3-Post%2Dtransplant_lymphoproliferative_disorder
3	lymphoproliferative	_
4	disorder	abstract-3-Post%2Dtransplant_lymphoproliferative_disorder)
5	,	(4)
6	chronic	(abstract-5
7	renal	(object-6)
8	insufficiency	abstract-5)
9	,	(7)
10	squamous	(abstract-8(animal-9
11	cell	animal-9)
12	carcinoma	_
13	of	_
14	the	(object-10
15	skin	abstract-8)object-10)
16	,	(11)
17	anemia	(abstract-12
18	secondary	_
19	to	_
20	chronic	(abstract-5
21	renal	(object-6)
22	insufficiency	abstract-5)
23	and	_
24	chemotherapy	(event-13)abstract-12)
25	,	(14)
26	and	(15)
27	hypertension	(abstract-16)
28	.	(17)
29	The	(person-18
30	patient	person-18)
31	is	(19)
32	here	(20)
33	for	(21)
34	followup	(event-22
35	visit	event-22)
36	and	(23)
37	chemotherapy	(event-13)
38	.	(24)
39	CHIEF	(abstract-25
40	COMPLAINT	abstract-25)
41	:	(26)
42	The	(person-18
43	patient	person-18)
44	is	(27)
45	here	(28)
46	for	(29)
47	followup	(event-22
48	visit	event-22)
49	and	(30)
50	chemotherapy	(event-13)
51	.	(31)
52	DIAGNOSES	(abstract-32)
53	:	(33)
54	1.	(34)
55	Posttransplant	(abstract-3-Post%2Dtransplant_lymphoproliferative_disorder
56	lymphoproliferative	_
57	disorder	abstract-3-Post%2Dtransplant_lymphoproliferative_disorder)
58	.	(35)
59	2.	(36)
60	Chronic	(abstract-5
61	renal	_
62	insufficiency	abstract-5)
63	.	(37)
64	3.	(abstract-38
65	Squamous	(abstract-8(animal-9
66	cell	animal-9)
67	carcinoma	_
68	of	_
69	the	(object-10
70	skin	abstract-38)abstract-8)object-10)
71	.	(39)
72	4.	(40)
73	Anemia	(abstract-12
74	secondary	_
75	to	_
76	chronic	(abstract-5
77	renal	(object-6)
78	insufficiency	abstract-5)
79	and	_
80	chemotherapy	(event-13)abstract-12)
81	.	(41)
82	5.	(42)
83	Hypertension	(abstract-16)
84	.	(43)
85	HISTORY	(abstract-44
86	OF	_
87	PRESENT	(abstract-45
88	ILLNESS	abstract-44)abstract-45)
89	:	(46)
90	A	(person-18
91	51	_
92	-	_
93	year	_
94	-	_
95	old	_
96	white	_
97	male	_
98	diagnosed	_
99	with	_
100	PTLD	(abstract-3-Post%2Dtransplant_lymphoproliferative_disorder)
101	in	_
102	latter	(time-47
103	half	_
104	of	_
105	2007	(time-48)person-18)time-47)
106	.	(49)
107	He	(person-18)
108	presented	(50)
109	with	(51)
110	symptoms	(abstract-52
111	of	_
112	increasing	(abstract-53
113	adenopathy	abstract-52)abstract-53)
114	,	(54)
115	abdominal	(abstract-55
116	pain	abstract-55)
117	,	(56)
118	weight	(abstract-57(abstract-58)
119	loss	abstract-57)
120	,	(59)
121	and	(60)
122	anorexia	(abstract-61)
123	.	(62)
124	He	(person-18)
125	did	(63)
126	not	(64)
127	seek	(65)
128	medical	(abstract-66
129	attention	abstract-66)
130	immediately	(67)
131	.	(68)
132	He	(person-18)
133	was	(69)
134	finally	(70)
135	hospitalized	(71)
136	by	(72)
137	the	(73)
138	renal	(abstract-74(event-75(object-6)
139	transplant	event-75)
140	service	abstract-74)
141	and	(76)
142	underwent	(77)
143	a	(event-78
144	lymph	(object-79
145	node	object-79)
146	biopsy	_
147	in	_
148	the	(object-80
149	groin	object-80)
150	,	_
151	which	_
152	showed	_
153	diagnosis	(abstract-81
154	of	_
155	large	(object-82
156	cell	_
157	lymphoma	event-78)abstract-81)object-82)
158	.	(83)
159	He	(person-18)
160	was	(84)
161	discussed	(85)
162	at	(86)
163	the	(event-87
164	hematopathology	(abstract-88)
165	conference	event-87)
166	.	(89)
167	Chemotherapy	(event-13
168	with	_
169	rituximab	(substance-90)
170	plus	_
171	cyclophosphamide	(substance-91)
172	,	_
173	daunorubicin	(substance-92)
174	,	_
175	vincristine	(substance-93)
176	,	_
177	and	_
178	prednisone	(substance-94)event-13)
179	was	(95)
180	started	(96)
181	.	(97)
182	First	(abstract-98
183	cycle	_
184	of	_
185	chemotherapy	(event-13)abstract-98)
186	was	(99)
187	complicated	(100)
188	by	(101)
189	sepsis	(abstract-102)
190	despite	(103)
191	growth	(abstract-104(abstract-105
192	factor	abstract-105)
193	support	abstract-104)
194	.	(106)
195	He	(person-18)
196	also	(107)
197	appeared	(108)
198	to	(109)
199	have	(110)
200	become	(111)
201	disoriented	(112)
202	either	(113)
203	secondary	(114)
204	to	(115)
205	sepsis	(abstract-102)
206	or	(116)
207	steroid	(abstract-117(substance-118)
208	therapy	abstract-117)
209	.	(119)
210	The	(person-18
211	patient	person-18)
212	has	(120)
213	received	(121)
214	5	(abstract-122
215	cycles	_
216	of	_
217	chemotherapy	(event-13)abstract-122)
218	to	(123)
219	date	(124)
220	.	(125)
221	He	(person-18)
222	did	(126)
223	not	(127)
224	keep	(128)
225	his	(event-129(person-18)
226	appointment	_
227	for	_
228	a	(abstract-130
229	PET	(abstract-131)
230	scan	abstract-130)
231	after	_
232	3	(abstract-132
233	cycles	event-129)abstract-132)
234	because	(133)
235	he	(person-18)
236	was	(134)
237	not	(135)
238	feeling	(136)
239	well	(137)
240	.	(138)
241	His	(abstract-139(person-18)
242	therapy	abstract-139)
243	has	(140)
244	been	(141)
245	interrupted	(142)
246	for	(143)
247	infection	(event-144
248	related	_
249	to	_
250	squamous	(abstract-8(animal-9
251	cell	animal-9)
252	cancer	event-144)abstract-8)
253	,	(145)
254	skin	(event-146(object-10)
255	surgery	event-146)
256	as	(147)
257	well	(148)
258	as	(149)
259	complaints	(event-150
260	of	_
261	chest	(object-151)
262	infection	event-150)
263	.	(152)
264	The	(person-18
265	patient	person-18)
266	is	(153)
267	here	(place-154)
268	for	(155)
269	the	(abstract-156
270	sixth	_
271	and	_
272	final	_
273	cycle	_
274	of	_
275	chemotherapy	(event-13)abstract-156)
276	.	(157)
277	He	(person-18)
278	states	(158)
279	he	(person-18)
280	feels	(159)
281	well	(160)
282	.	(161)
283	He	(person-18)
284	denies	(162)
285	any	(abstract-163
286	nausea	(abstract-164)abstract-163)
287	,	(165)
288	vomiting	(event-166)
289	,	(167)
290	cough	(event-168)
291	,	(169)
292	shortness	(abstract-170
293	of	_
294	breath	(abstract-171)abstract-170)
295	,	(172)
296	chest	(abstract-173(object-151)
297	pain	abstract-173)
298	or	(174)
299	fatigue	(abstract-175)
300	.	(176)
301	He	(person-18)
302	denies	(177)
303	any	(abstract-178
304	tingling	_
305	or	_
306	numbness	_
307	in	_
308	his	(object-179(person-18)
309	fingers	abstract-178)object-179)
310	.	(180)
311	Review	(abstract-181
312	of	_
313	systems	(abstract-182)abstract-181)
314	is	(183)
315	otherwise	(184)
316	entirely	(185)
317	negative	(186)
318	.	(187)
319	Performance	(abstract-188
320	status	_
321	on	_
322	the	(abstract-189
323	ECOG	_
324	scale	abstract-188)abstract-189)
325	is	(190)
326	1	(abstract-188)
327	PHYSICAL	(abstract-191
328	EXAMINATION	abstract-191)
329	:	(192)
330	VITAL	(abstract-193
331	SIGNS	abstract-193)
332	:	(194)
333	He	(person-18)
334	is	(195)
335	afebrile	(196)
336	.	(197)
337	Blood	(abstract-198(substance-199)
338	pressure	abstract-198)
339	161	(abstract-198
340	/	_
341	80	abstract-198)
342	,	(200)
343	pulse	(abstract-201)
344	65	(abstract-201)
345	,	(202)
346	weight	(abstract-58)
347	71.5	(abstract-58
348	kg	abstract-58)
349	,	(203)
350	which	(204)
351	is	(205)
352	essentially	(206)
353	unchanged	(207)
354	from	(208)
355	his	(event-209(person-18)
356	prior	_
357	visit	event-209)
358	.	(210)
359	There	(211)
360	is	(212)
361	mild	(abstract-213
362	pallor	abstract-213)
363	noted	(214)
364	.	(215)
365	There	(216)
366	is	(217)
367	no	(218)
368	icterus	(abstract-219)
369	,	(220)
370	adenopathy	(abstract-53)
371	or	(221)
372	petechiae	(object-222)
373	noted	(223)
374	.	(224)
375	CHEST	(object-151)
376	:	(225)
377	Clear	(226)
378	to	(227)
379	auscultation	(event-228)
380	.	(229)
381	CARDIOVASCULAR	(abstract-230)
382	:	(231)
383	S1	(abstract-232)
384	and	(233)
385	S2	(abstract-234)
386	normal	(235)
387	with	(236)
388	regular	(event-237
389	rate	_
390	and	_
391	rhythm	event-237)
392	.	(238)
393	Systolic	(event-239
394	flow	_
395	murmur	event-239)
396	is	(240)
397	best	(241)
398	heard	(242)
399	in	(243)
400	the	(place-244
401	pulmonary	_
402	area	place-244)
403	.	(245)
404	ABDOMEN	(object-246)
405	:	(247)
406	Soft	(248)
407	and	(249)
408	nontender	(250)
409	with	(251)
410	no	(252)
411	organomegaly	(event-253)
412	.	(254)
413	Renal	(event-75(object-6)
414	transplant	event-75)
415	is	(255)
416	noted	(256)
417	in	(257)
418	the	(object-258
419	right	_
420	lower	_
421	quadrant	object-258)
422	with	(259)
423	a	(object-260
424	scar	object-260)
425	present	(261)
426	.	(262)
427	EXTREMITIES	(abstract-263)
428	:	(264)
429	Reveal	(265)
430	no	(abstract-266
431	edema	abstract-266)
432	.	(267)
433	LABORATORY	(abstract-268
434	DATA	abstract-268)
435	:	(269)
436	CBC	(abstract-270(abstract-271-Complete_blood_count)
437	from	_
438	today	(time-272)abstract-270)
439	shows	(273)
440	white	(abstract-274
441	count	_
442	of	_
443	9.6	(abstract-274)
444	with	_
445	a	(abstract-275
446	normal	_
447	differential	abstract-274)abstract-275)
448	,	(276)
449	ANC	(abstract-277)
450	of	(278)
451	7400	(abstract-277)
452	,	(279)
453	hemoglobin	(abstract-280)
454	8.9	(abstract-280)
455	,	(281)
456	hematocrit	(abstract-282)
457	26.5	(abstract-282)
458	with	(283)
459	an	(abstract-284
460	MCV	_
461	of	_
462	109	(abstract-284)abstract-284)
463	,	(285)
464	and	(286)
465	platelet	(abstract-287(object-288)
466	count	_
467	of	_
468	220,000	(abstract-287)abstract-287)
469	.	(289)
470	ASSESSMENT	(abstract-290)
471	AND	(291)
472	PLAN	(abstract-292)
473	:	(293)
474	1.	(294)
475	Diffuse	(295)
476	large	(object-82
477	B	(object-296
478	-	_
479	cell	object-296)
480	lymphoma	object-82)
481	following	(297)
482	transplantation	(event-298)
483	.	(299)
484	The	(person-18
485	patient	person-18)
486	is	(300)
487	to	(301)
488	receive	(302)
489	his	(abstract-303(person-18)
490	sixth	_
491	and	_
492	final	_
493	cycle	_
494	of	_
495	chemotherapy	(event-13)abstract-303)
496	today	(time-272)
497	.	(304)
498	PET	(abstract-130(abstract-131)
499	scan	abstract-130)
500	has	(305)
501	been	(306)
502	ordered	(307)
503	to	(308)
504	be	(309)
505	done	(310)
506	within	(311)
507	2	(time-312
508	weeks	time-312)
509	.	(313)
510	He	(person-18)
511	will	(314)
512	see	(315)
513	me	(person-316)
514	back	(317)
515	for	(318)
516	the	(event-319
517	visit	_
518	in	_
519	3	(time-320
520	weeks	event-319)time-320)
521	with	(321)
522	CBC	(abstract-271-Complete_blood_count)
523	,	(322)
524	CMP	(abstract-323-Comprehensive_metabolic_panel)
525	,	(324)
526	and	(325)
527	LDH	(abstract-326-Lactate_dehydrogenase)
528	.	(327)
529	2.	(328)
530	Chronic	(abstract-5
531	renal	_
532	insufficiency	abstract-5)
533	.	(329)
534	3.	(330)
535	Anemia	(abstract-12
536	secondary	_
537	to	_
538	chronic	(event-331
539	renal	(object-6)
540	failure	event-331)
541	and	_
542	chemotherapy	(event-13)abstract-12)
543	.	(332)
544	He	(person-18)
545	is	(333)
546	to	(334)
547	continue	(335)
548	on	(336)
549	his	(abstract-337(person-18)
550	regimen	_
551	of	_
552	growth	(abstract-104(abstract-105
553	factor	abstract-105)
554	support	abstract-337)abstract-104)
555	.	(338)
556	4.	(339)
557	Hypertension	(abstract-16)
558	.	(340)
559	This	(abstract-16)
560	is	(341)
561	elevated	(342)
562	today	(time-272)
563	because	(343)
564	he	(event-344(person-18)
565	held	_
566	his	(substance-345(person-18)
567	meds	substance-345)
568	because	_
569	he	(person-18)
570	is	_
571	getting	_
572	rituximab	(substance-346)event-344)
573	other	(347)
574	than	(348)
575	that	(event-344)
576	this	(abstract-16)
577	is	(349)
578	well	(350)
579	controlled	(351)
580	.	(352)
581	His	(abstract-323-Comprehensive_metabolic_panel(person-18)
582	CMP	abstract-323-Comprehensive_metabolic_panel)
583	is	(353)
584	pending	(354)
585	from	(355)
586	today	(time-272)
587	.	(356)
588	5.	(357)
589	Squamous	(abstract-8(abstract-8(animal-9
590	cell	animal-9)
591	carcinoma	abstract-8)
592	of	_
593	the	(object-10
594	skin	abstract-8)object-10)
595	.	(358)
596	The	(object-359
597	scalp	object-359)
598	is	(360)
599	well	(361)
600	healed	(362)
601	.	(363)
602	He	(person-18)
603	still	(364)
604	has	(365)
605	an	(object-366
606	open	_
607	wound	_
608	on	_
609	the	(object-367
610	right	_
611	posterior	_
612	aspect	_
613	of	_
614	his	(object-368(person-18)
615	trunk	object-366)object-367)object-368)
616	.	(369)
617	This	(object-366)
618	has	(370)
619	no	(371)
620	active	(abstract-372
621	drainage	abstract-372)
622	,	(373)
623	but	(374)
624	it	(object-366)
625	is	(375)
626	yet	(376)
627	to	(377)
628	heal	(378)
629	.	(379)
630	This	(object-366)
631	probably	(380)
632	will	(381)
633	heal	(382)
634	by	(383)
635	secondary	(abstract-384
636	intention	abstract-384)
637	once	(385)
638	chemotherapy	(event-13)
639	is	(386)
640	finished	(387)
641	.	(388)
642	Prescription	(substance-389
643	for	_
644	prednisone	(substance-390)
645	as	_
646	part	_
647	of	_
648	his	(event-13(person-18)
649	chemotherapy	substance-389)event-13)
650	has	(391)
651	been	(392)
652	given	(393)
653	to	(394)
654	him	(person-18)
655	.	(395)
# end document

